Author Topic: US Citizen X-ray scanning company awarded contract for Cancer research at NCI  (Read 5967 times)

0 Members and 1 Guest are viewing this topic.


  • Guest

VACISĀ® XPL Passenger Vehicle Scanning System

A compact, ultrahigh-throughput, full-vehicle nonintrusive scanning solution for even the busiest checkpoints


SAIC's VACISĀ® XPL passenger vehicle scanning system helps customs, military, and security personnel screen 100 percent of vehicles at critical checkpoints. The system assists inspectors in locating even single firearms, as well as ammunition, drugs, and similar items hidden in vehicles. The VACIS XPL system's low-dose technology allows drivers and passengers to remain in their vehicles during the scan, enabling each system to scan hundreds of vehicles per hour with minimal impact on checkpoint operations.

The VACIS XPL system provides a powerful combination of scanning features:

    * Free-flow operation screens vehicles moving at typical checkpoint speeds without requiring them to stop or occupants to exit.
    * Bumper-to-bumper, roof-to-pavement scanning allows every part of the vehicle to be quickly and efficiently screened.
    * High-resolution X-ray imaging assists inspectors in locating metallic threats such as weapons and ammunition.
    * Material discrimination helps inspectors locate organic threats such as explosives and drugs.
    * Compact system fits directly into existing vehicle lanes at most facilities.
    * Remote, centralized image analysis can be performed nearby or hundreds of miles away.
    * Low dose per scan fully complies with dose limits specified in ANSI N43.17.


The VACIS XPL passenger vehicle scanning system continues SAIC's tradition of helping customs, military, and security personnel screen more vehicles for weapons, explosives, drugs, and other suspicious items at critical checkpoints.

SAIC is a world leader in nonintrusive imaging technology, with hundreds of systems installed for government and commercial clients around the world. Every VACIS system is available with SAIC's dedicated installation, training, maintenance and technical support.

VACIS is a trademark and/or registered trademark of Science Applications International Corp. in the United States and/or other countries.

The VACIS XPL system and its technology are subject to U.S. Export Administration Regulations. Diversion contrary to U.S. law is prohibited. This technology may not be exported, re-exported, resold, transferred or transshipped without prior authorization by the U.S. government.

SAIC's facility for the manufacture of the VACIS XPL system is registered to ISO 9001:2000 standards.

Due to our efforts to continually improve this product, specifications, dimensions and operating procedures are subject to change without notice. All specifications and measurements are approximate, based on the standard configuration; results may vary with the application and environment.

SAIC Awarded Major Contract to Support the National Cancer Institute
Posted on: Monday, 29 September 2008, 09:00 CDT

SAN DIEGO and MCLEAN, Va., Sept. 29 /PRNewswire-FirstCall/ -- Science Applications International Corporation today announced that its wholly-owned subsidiary SAIC-Frederick, Inc. has been awarded a follow-on contract by the National Cancer Institute (NCI) to provide operations and technical support to NCI's Federally Funded Research and Development Center (FFRDC) in Frederick, Md.

The single award contract has a three-year base period of performance, five one-year award-term options, and one two-year option, for an estimated contract value of $5.2 billion if all options are exercised.

The FFRDC is one of only 38 national laboratories in the United States and the only one solely dedicated to cancer and HIV/AIDS research. The FFRDC strives to develop new technologies and translate scientific discoveries into novel agents for the prevention, diagnosis, and treatment of cancer and AIDS. SAIC has been the operations and technical support contractor for the FFRDC since 1995, and in 2000 formed SAIC-Frederick to continue the work. The contract is the largest single research contract awarded by the Department of Health and Human Services.

Under the new contract, SAIC-Frederick will provide operations and technical support to the overall mission of the NCI within three major focus areas: basic research, translational research and development, and preclinical research and development. SAIC-Frederick employs more than 1,700 scientific, technical, and support personnel, and manages a comprehensive suite of cutting-edge advanced technologies in genomics, proteomics, nanotechnology, optical and electron microscopy, and high-performance biomedical computing.

 Under the current contract, SAIC-Frederick supports more than 300 clinical trials, and manages a pilot program of community hospitals in 14 states studying how best to bring the latest, evidence-based cancer care to rural, inner-city, and underserved patients. It also operates two biopharmaceutical manufacturing facilities --- one for NCI and the other for the National Institute of Allergy and Infectious Diseases' Vaccine Research Center. These facilities produce drugs, vaccines, and other biologics for use in clinical trials.

"We appreciate the confidence NCI has shown in SAIC over the past 13 years and look forward to continuing our work to help deliver preventive, diagnostic, and therapeutic products to cancer patients," said Charles Koontz, SAIC group president.

About SAIC

SAIC is a FORTUNE 500(R) scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. The company's approximately 44,000 employees serve customers in the Department of Defense, the intelligence community, the U.S. Department of Homeland Security, other U.S. Government civil agencies and selected commercial markets. SAIC had annual revenues of $8.9 billion for its fiscal year ended January 31, 2008. For more information, visit

SAIC: From Science to Solutions(R)

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in SAIC's Annual Report on Form 10-K for the period ended January 31, 2008, and other such filings that SAIC makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

Offline Dig

  • All eyes are opened, or opening, to the rights of man.
  • Member
  • *****
  • Posts: 63,090
    • Git Ureself Edumacated
This is like Dr. Mengele getting a contract for the study of the effectiveness of dental tools.
All eyes are opened, or opening, to the rights of man. The general spread of the light of science has already laid open to every view the palpable truth, that the mass of mankind has not been born with saddles on their backs, nor a favored few booted and spurred, ready to ride them legitimately